DeCODE partners sequence-based clinical diagnostics IP with start-up NextCODE
Start-up NextCODE Health LLC received exclusive rights over the next five years to Icelandic life sciences company deCODE genetics EHF’s genomics platform, which will allow NextCODE to develop sequence-based clinical diagnostics. The deal is concurrent with deCODE’s spin off of NextCODE, which also received $15mm in Series A financing from Polaris Partners and Arch Venture Partners, and will be led by former deCODE key executives.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Drug Discovery Technologies
- Drug Discovery Technologies
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.